Eintrag weiter verarbeiten
No evidence of impediment by three common classes of prescription drugs to post-stroke aphasia recovery in a retrospective longitudinal sample
Gespeichert in:
| Zeitschriftentitel: | PLOS ONE |
|---|---|
| Personen und Körperschaften: | , , , |
| In: | PLOS ONE, 17, 2022, 6, S. e0270135 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Public Library of Science (PLoS)
|
| Schlagwörter: |
| author_facet |
Stockbridge, Melissa D. Keser, Zafer Bunker, Lisa D. Hillis, Argye E. Stockbridge, Melissa D. Keser, Zafer Bunker, Lisa D. Hillis, Argye E. |
|---|---|
| author |
Stockbridge, Melissa D. Keser, Zafer Bunker, Lisa D. Hillis, Argye E. |
| spellingShingle |
Stockbridge, Melissa D. Keser, Zafer Bunker, Lisa D. Hillis, Argye E. PLOS ONE No evidence of impediment by three common classes of prescription drugs to post-stroke aphasia recovery in a retrospective longitudinal sample Multidisciplinary |
| author_sort |
stockbridge, melissa d. |
| spelling |
Stockbridge, Melissa D. Keser, Zafer Bunker, Lisa D. Hillis, Argye E. 1932-6203 Public Library of Science (PLoS) Multidisciplinary http://dx.doi.org/10.1371/journal.pone.0270135 <jats:p>A number of pharmaceuticals have been identified as potential adjuvants to speech language therapy following stroke, but it is also important to consider which pharmaceuticals may result in a <jats:italic>less</jats:italic> robust recovery. Here we examine whether post-stroke language recovery was meaningfully impeded by cholinergic, GABAergic, or dopaminergic medications patients received. Eighty participants with left hemisphere stroke were examined retrospectively to see whether the use of one of these three classes of medication prior to admission for acute stroke, during their inpatient stay, or at discharge was associated with differences in recovery on three common measures of language. While prescription of any of the candidate drugs was relatively uncommon, groups were very well matched for many common factors that impact performance. When age, education, and acute lesion volume were controlled, there were no significant differences in performance among those taking cholinergic, GABAergic, or dopaminergic medications and those who were not. Those who experienced a “good recovery” of language (≥10% improvement on any one language measure over time) had similar exposure to these drugs to those with a poor recovery. This work represents a first look at these drug classes with regard to their effects on the recovery of language after stroke and should not be interpreted as resolving all potential for concern, but these results do offer modest reassurance that these common classes of pharmacotherapy, when given for short periods in this population, do not appear to have marked deleterious effects on post-stroke recovery of language.</jats:p> No evidence of impediment by three common classes of prescription drugs to post-stroke aphasia recovery in a retrospective longitudinal sample PLOS ONE |
| doi_str_mv |
10.1371/journal.pone.0270135 |
| facet_avail |
Online Free |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTM3MS9qb3VybmFsLnBvbmUuMDI3MDEzNQ |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTM3MS9qb3VybmFsLnBvbmUuMDI3MDEzNQ |
| institution |
DE-Gla1 DE-Zi4 DE-15 DE-Rs1 DE-Pl11 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
| imprint |
Public Library of Science (PLoS), 2022 |
| imprint_str_mv |
Public Library of Science (PLoS), 2022 |
| issn |
1932-6203 |
| issn_str_mv |
1932-6203 |
| language |
English |
| mega_collection |
Public Library of Science (PLoS) (CrossRef) |
| match_str |
stockbridge2022noevidenceofimpedimentbythreecommonclassesofprescriptiondrugstopoststrokeaphasiarecoveryinaretrospectivelongitudinalsample |
| publishDateSort |
2022 |
| publisher |
Public Library of Science (PLoS) |
| recordtype |
ai |
| record_format |
ai |
| series |
PLOS ONE |
| source_id |
49 |
| title |
No evidence of impediment by three common classes of prescription drugs to post-stroke aphasia recovery in a retrospective longitudinal sample |
| title_unstemmed |
No evidence of impediment by three common classes of prescription drugs to post-stroke aphasia recovery in a retrospective longitudinal sample |
| title_full |
No evidence of impediment by three common classes of prescription drugs to post-stroke aphasia recovery in a retrospective longitudinal sample |
| title_fullStr |
No evidence of impediment by three common classes of prescription drugs to post-stroke aphasia recovery in a retrospective longitudinal sample |
| title_full_unstemmed |
No evidence of impediment by three common classes of prescription drugs to post-stroke aphasia recovery in a retrospective longitudinal sample |
| title_short |
No evidence of impediment by three common classes of prescription drugs to post-stroke aphasia recovery in a retrospective longitudinal sample |
| title_sort |
no evidence of impediment by three common classes of prescription drugs to post-stroke aphasia recovery in a retrospective longitudinal sample |
| topic |
Multidisciplinary |
| url |
http://dx.doi.org/10.1371/journal.pone.0270135 |
| publishDate |
2022 |
| physical |
e0270135 |
| description |
<jats:p>A number of pharmaceuticals have been identified as potential adjuvants to speech language therapy following stroke, but it is also important to consider which pharmaceuticals may result in a <jats:italic>less</jats:italic> robust recovery. Here we examine whether post-stroke language recovery was meaningfully impeded by cholinergic, GABAergic, or dopaminergic medications patients received. Eighty participants with left hemisphere stroke were examined retrospectively to see whether the use of one of these three classes of medication prior to admission for acute stroke, during their inpatient stay, or at discharge was associated with differences in recovery on three common measures of language. While prescription of any of the candidate drugs was relatively uncommon, groups were very well matched for many common factors that impact performance. When age, education, and acute lesion volume were controlled, there were no significant differences in performance among those taking cholinergic, GABAergic, or dopaminergic medications and those who were not. Those who experienced a “good recovery” of language (≥10% improvement on any one language measure over time) had similar exposure to these drugs to those with a poor recovery. This work represents a first look at these drug classes with regard to their effects on the recovery of language after stroke and should not be interpreted as resolving all potential for concern, but these results do offer modest reassurance that these common classes of pharmacotherapy, when given for short periods in this population, do not appear to have marked deleterious effects on post-stroke recovery of language.</jats:p> |
| container_issue |
6 |
| container_start_page |
0 |
| container_title |
PLOS ONE |
| container_volume |
17 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792332226663284741 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T13:53:27.823Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=No+evidence+of+impediment+by+three+common+classes+of+prescription+drugs+to+post-stroke+aphasia+recovery+in+a+retrospective+longitudinal+sample&rft.date=2022-06-24&genre=article&issn=1932-6203&volume=17&issue=6&pages=e0270135&jtitle=PLOS+ONE&atitle=No+evidence+of+impediment+by+three+common+classes+of+prescription+drugs+to+post-stroke+aphasia+recovery+in+a+retrospective+longitudinal+sample&aulast=Hillis&aufirst=Argye+E.&rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0270135&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792332226663284741 |
| author | Stockbridge, Melissa D., Keser, Zafer, Bunker, Lisa D., Hillis, Argye E. |
| author_facet | Stockbridge, Melissa D., Keser, Zafer, Bunker, Lisa D., Hillis, Argye E., Stockbridge, Melissa D., Keser, Zafer, Bunker, Lisa D., Hillis, Argye E. |
| author_sort | stockbridge, melissa d. |
| container_issue | 6 |
| container_start_page | 0 |
| container_title | PLOS ONE |
| container_volume | 17 |
| description | <jats:p>A number of pharmaceuticals have been identified as potential adjuvants to speech language therapy following stroke, but it is also important to consider which pharmaceuticals may result in a <jats:italic>less</jats:italic> robust recovery. Here we examine whether post-stroke language recovery was meaningfully impeded by cholinergic, GABAergic, or dopaminergic medications patients received. Eighty participants with left hemisphere stroke were examined retrospectively to see whether the use of one of these three classes of medication prior to admission for acute stroke, during their inpatient stay, or at discharge was associated with differences in recovery on three common measures of language. While prescription of any of the candidate drugs was relatively uncommon, groups were very well matched for many common factors that impact performance. When age, education, and acute lesion volume were controlled, there were no significant differences in performance among those taking cholinergic, GABAergic, or dopaminergic medications and those who were not. Those who experienced a “good recovery” of language (≥10% improvement on any one language measure over time) had similar exposure to these drugs to those with a poor recovery. This work represents a first look at these drug classes with regard to their effects on the recovery of language after stroke and should not be interpreted as resolving all potential for concern, but these results do offer modest reassurance that these common classes of pharmacotherapy, when given for short periods in this population, do not appear to have marked deleterious effects on post-stroke recovery of language.</jats:p> |
| doi_str_mv | 10.1371/journal.pone.0270135 |
| facet_avail | Online, Free |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTM3MS9qb3VybmFsLnBvbmUuMDI3MDEzNQ |
| imprint | Public Library of Science (PLoS), 2022 |
| imprint_str_mv | Public Library of Science (PLoS), 2022 |
| institution | DE-Gla1, DE-Zi4, DE-15, DE-Rs1, DE-Pl11, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
| issn | 1932-6203 |
| issn_str_mv | 1932-6203 |
| language | English |
| last_indexed | 2024-03-01T13:53:27.823Z |
| match_str | stockbridge2022noevidenceofimpedimentbythreecommonclassesofprescriptiondrugstopoststrokeaphasiarecoveryinaretrospectivelongitudinalsample |
| mega_collection | Public Library of Science (PLoS) (CrossRef) |
| physical | e0270135 |
| publishDate | 2022 |
| publishDateSort | 2022 |
| publisher | Public Library of Science (PLoS) |
| record_format | ai |
| recordtype | ai |
| series | PLOS ONE |
| source_id | 49 |
| spelling | Stockbridge, Melissa D. Keser, Zafer Bunker, Lisa D. Hillis, Argye E. 1932-6203 Public Library of Science (PLoS) Multidisciplinary http://dx.doi.org/10.1371/journal.pone.0270135 <jats:p>A number of pharmaceuticals have been identified as potential adjuvants to speech language therapy following stroke, but it is also important to consider which pharmaceuticals may result in a <jats:italic>less</jats:italic> robust recovery. Here we examine whether post-stroke language recovery was meaningfully impeded by cholinergic, GABAergic, or dopaminergic medications patients received. Eighty participants with left hemisphere stroke were examined retrospectively to see whether the use of one of these three classes of medication prior to admission for acute stroke, during their inpatient stay, or at discharge was associated with differences in recovery on three common measures of language. While prescription of any of the candidate drugs was relatively uncommon, groups were very well matched for many common factors that impact performance. When age, education, and acute lesion volume were controlled, there were no significant differences in performance among those taking cholinergic, GABAergic, or dopaminergic medications and those who were not. Those who experienced a “good recovery” of language (≥10% improvement on any one language measure over time) had similar exposure to these drugs to those with a poor recovery. This work represents a first look at these drug classes with regard to their effects on the recovery of language after stroke and should not be interpreted as resolving all potential for concern, but these results do offer modest reassurance that these common classes of pharmacotherapy, when given for short periods in this population, do not appear to have marked deleterious effects on post-stroke recovery of language.</jats:p> No evidence of impediment by three common classes of prescription drugs to post-stroke aphasia recovery in a retrospective longitudinal sample PLOS ONE |
| spellingShingle | Stockbridge, Melissa D., Keser, Zafer, Bunker, Lisa D., Hillis, Argye E., PLOS ONE, No evidence of impediment by three common classes of prescription drugs to post-stroke aphasia recovery in a retrospective longitudinal sample, Multidisciplinary |
| title | No evidence of impediment by three common classes of prescription drugs to post-stroke aphasia recovery in a retrospective longitudinal sample |
| title_full | No evidence of impediment by three common classes of prescription drugs to post-stroke aphasia recovery in a retrospective longitudinal sample |
| title_fullStr | No evidence of impediment by three common classes of prescription drugs to post-stroke aphasia recovery in a retrospective longitudinal sample |
| title_full_unstemmed | No evidence of impediment by three common classes of prescription drugs to post-stroke aphasia recovery in a retrospective longitudinal sample |
| title_short | No evidence of impediment by three common classes of prescription drugs to post-stroke aphasia recovery in a retrospective longitudinal sample |
| title_sort | no evidence of impediment by three common classes of prescription drugs to post-stroke aphasia recovery in a retrospective longitudinal sample |
| title_unstemmed | No evidence of impediment by three common classes of prescription drugs to post-stroke aphasia recovery in a retrospective longitudinal sample |
| topic | Multidisciplinary |
| url | http://dx.doi.org/10.1371/journal.pone.0270135 |